Davis Polk, Jingtian & Gongcheng and Harney Westwood advised Laekna, while Cooley and Commerce & Finance Law Offices advised the sole sponsor and the underwriters. Laekna,...
Laekna’s HK$791 Million Initial Public Offering
Tims China’s Warrant Exchange Offer
Kirkland & Ellis LLP advised Tims China on the deal, while Davis Polk advised the dealer manager and solicitation agent. TH International Limited (“Tims China” or the...
ZJLD Group’s HK$5.3 Billion Initial Public Offering
Davis Polk advised ZJLD Group on the offering, while Cleary Gottlieb advised the joint sponsors, and the overall coordinators, joint global coordinators, joint bookrunners, and joint...
China Resources Beer’s RMB12.3 Billion Acquisition of Jinsha Winery
Davis Polk is advising China Resources Beer as its international counsel on the deal. China Resources Beer (Holdings) Company Limited has announced the acquisition of 55.19%...
InnoCare Pharma Limited’s Listing on Shanghai Stock Exchange
Fangda, Davis Polk and Conyers advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed a successful listing on the Shanghai Stock Exchange’s STAR Market. InnoCare...
Tencent Music Entertainment Group’s Secondary Listing on The HKSE
Slaughter and May, Maples and Calder, Davis Polk & Wardwell and Han Kun Law Offices advised Tencent Holdings Limited on the deal. Freshfields Bruckhaus Deringer and...
Interra Acquisition Corporation’s SPAC Listing
Davis Polk has advised Interra Acquisition Corporation, while Freshfields Bruckhaus Deringer has advised ABCI Capital and J.P. Morgan. ABCI Capital and J.P. Morgan, the joint sponsors...
Taibang Biologic Group’s $300 Million Equity Raising
Davis Polk advised Taibang Biologic Group on the transaction. Taibang Biologic Group (previously listed as China Biologic Products Holdings on the Nasdaq Global Select Market under...
Tuya’s HK$140 Million Initial Public Offering
Maples Group and Davis Polk & Wardwell acted as legal advisers to Tuya as to Hong Kong and US laws and Jia Yuan Law Offices as...
Li Auto’s $2 Billion At-The-Market Offering
Davis Polk, working alongside King & Wood Mallesons advised the sales agents in the offering. Li Auto Inc. announced its at-the-market offering program, under which Li Auto may...
Laekna Therapeutics’ $61 Million Series D Financing
Davis Polk advised Laekna Therapeutics in the transaction. Laekna Therapeutics completed its $61 million Series D financing led by CS Capital with support from Worldstar, and Infinity...
CNOOC’s US$4.38 Billion Initial Public Offering
Davis Polk advised CNOOC Limited on the IPO. CNOOC Limited (CNOOC) announced its initial public offering and listing on the Shanghai Stock Exchange. The gross proceeds...